Fall 2019 newsletter

Click here to download a pdf copy of the DNA Software Fall Newsletter

Read more ›

Large Scale Multiplex PCR Panel Design

Large Scale Multiplex PCR Panel Design with >95% Success in Hours, Not Months
John SantaLucia, Ph.D., co-founder and CEO, DNA Software
Abstract: We aim to solve the problem of multiplex PCR design by Read more ›

DNAS releases PanelPlex

Infectious disease molecular diagnostic(MDx) assays require rapid identification of pathogens and their drug resistance profiles in clinical samples use a highly multiplexed molecular approach. The market pull for such MDx assays has led to the software solution, Read more ›

DNA Software receives FastTrack award

ANN ARBOR, MICH. – At its annual meeting, Ann Arbor SPARK presented its annual FastTrack awards to 17 Washtenaw County-based companies that have demonstrated fast growth. Several of the 2016 and 2017 FastTrack award recipients Read more ›

DNAS cited in Science Advances

Early identification of pathogens is essential for limiting development of therapy-resistant pathogens and mitigating infectious disease outbreaks. Most bacterial detection schemes use target-specific probes to differentiate pathogen species, creating time and cost inefficiencies in identifying Read more ›

Increase Accuracy of Assure-CNV

A world class agricultural company compared the capabilities of Assure-CNV to their current workflow. This customer found Assure-CNV increased accuracy with 12 standard deviations versus the 8 provided by their traditional method. Their standard workflow also Read more ›

Better Antisense Design Without the Trial and Error:  Problems we Solve

Most researchers use naïve strategies to design antisense oligonucleotides.  However, to maximize assay sensitivity and specificity one must consider probe and target sequence and their respective and combined chemistries.  Read more ›

Real Cost of Multiplex

This conversation is consistent with our feedback from customers throughout the years.   Building a successful multiplex is hard, expensive and time-consuming.  Often times we work with customers after they’ve already tried “going it alone”.  We unfortunately Read more ›

InSilixa Inc. and DNA Software Inc. enter into agreement to develop state-of-the-art high-multiplex infectious disease panels for commercialization on InSilixa’s CMOS biochip platform

See press coverage at Genome Web

Infectious disease molecular diagnostic (MDx) assays developed in partnership with inSilixa Read more ›

How do you design a successful multiplex PCR?

Read more ›